Neutral
BBOT (NASDAQ: BBOT) registers 63.05M common shares for resale
BridgeBio Oncology Therapeutics, Inc. (BBOT) has registered 63.05 million common shares for resale by existing securityholders through a post-effectiv...
Neutral
BridgeBio Oncology Therapeutics, Inc. (BBOT) has registered 63.05 million common shares for resale by existing securityholders through a post-effectiv...